SK Capital completed the acquisition of the Blow-Fill-Seal Sterile CDMO business of Catalent.

SK Capital, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, completed the acquisition of the Blow-Fill-Seal Sterile CDMO business of Catalent, a pharmaceutical company. Financial terms were not disclosed. ”Paul is a CDMO industry veteran who brings sterile production experience and contemporary leadership skills to ensure an environment committed to operational excellence, customer delight, innovation and a partnership-driven approach for Woodstock’s customers, suppliers and employees,” Aaron Davenport, SK Capital Managing Director.